Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
Previous findings showed that the anticancer effects of combined γ-tocotrienol and peroxisome proliferator activated receptor γ (PPARγ) antagonist treatment caused a large reduction in PPARγ expression. However, other studies suggest that the antiproliferative effects of γ-tocotrienol and/or PPARγ a...
Saved in:
| Main Authors: | Abhita Malaviya, Paul W. Sylvester |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2014/439146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
by: Masamichi Yamashita
Published: (2008-01-01) -
Nutraceuticals as Ligands of PPARγ
by: Meera Penumetcha, et al.
Published: (2012-01-01) -
PPAR-γ in the Cardiovascular System
by: Sheng Zhong Duan, et al.
Published: (2008-01-01) -
Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
by: Masahito Shimizu, et al.
Published: (2008-01-01) -
Prostaglandins as PPARγ Modulators in Adipogenesis
by: Ko Fujimori
Published: (2012-01-01)